RVPH - Reviva Pharmaceuticals, Inc. Narxning foydaga va o‘sish sur’atiga nisbati
Shizofreniyani davolash uchun mo‘ljallangan innovatsion brilaroksazin pipeline’i Reviva Pharmaceuticals (RVPH) aksiyalarining narx dinamikasiga ta’sir ko‘rsatmoqda. PEG koeffitsiyenti dinamikasi ushbu tebranishlarni vizuallashtiradi, bunda 0.00 ushbu metrikaning so‘nggi qiymatini aks ettiradi. Yangi antipsixotiklar ishlab chiquvchi institutlar bilan hamkorlik va bemorlarning muqobil variantlarga o‘tishini minimallashtiruvchi yopiq shifokorlar qo‘llab-quvvatlash ekotizimi fundamental ko‘rsatkichlarni mustahkamlaydi.
Reviva Pharmaceuticals (RVPH) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi statistikasi:
- emitentning balans qiymati statistikasi:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati Reviva Pharmaceuticals|RVPH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati revivapharma.com|RVPH - Kompaniya qarzlari|Qarzlarning balans kapitallashuviga nisbati Reviva Pharmaceuticals Holdings|RVPH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Reviva Pharmaceuticals|Tezkor likvidlik koeffitsiyenti revivapharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
RVPH - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Reviva Pharmaceuticals|RVPH - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Reviva Pharmaceuticals, Inc.|RVPH - PEG multiplikatori|EV/EBITDA multiplikatori Reviva Pharmaceuticals Holdings|RVPH - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Reviva Pharmaceuticals|RVPH - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi revivapharma.com|RVPH - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Reviva Pharmaceuticals
Kompaniyaning fundamental tahlili:Reviva Pharmaceuticals Holdings Inc. - RVPH
PEG koeffitsiyenti joriy narxning adolatli ekanligini aniqlash uchun P/E koeffitsiyentini foyda o'sish sur'atlari bilan solishtiradi. Birga solishtirganda birdan past qiymatlar aktivning kengayishiga nisbatan qadrsizlanganligidan dalolat beradi. Baholashning foyda dinamikasiga nisbatini tahlil qilish investorlarga fundamental tendentsiyalardan spekulyativ shovqinlarni ajratib olish imkonini beradi. Ushbu grafik Reviva Pharmaceuticals (RVPH) uchun juda muhimdir. Bu yerdagi o'sish potentsiali Brinavazine uchun III bosqich sinovlari yakunlangach, hamkorlar bilan sinergiya hosil bo'lishiga bog'liq.
Raqobatdosh kompaniyalar
BIIB - O‘sish sur’atiga tuzatilgan narx-foyda|Neurocrine Biosciences Inc - Narx-foyda va o‘sish multiplikatori|Regencell Corp - Narxning foydaga va o‘sish sur’atiga nisbati|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati acadia-pharm.com ACAD|XENE (Xenon) - Narx-foyda va o‘sish multiplikatori|VKTX (Viking Therapeutics Inc) - Narxning foydaga va o‘sish sur’atiga nisbati|SUPN (Supernus Pharma) - PEG multiplikatori|PEG multiplikatori Catalyst Corp|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics)|HRMY (harmonybiosciences.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Trevi Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Corp)|AVXL: PEG multiplikatori|ceribell.com (CBLL) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Prothena Corporation plc|ALEC: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|Narx-foyda va o‘sish multiplikatori omeros.com OMER|PEG multiplikatori NGNE (Neurogene Inc.)|PEG multiplikatori acimmune.com ACIU|Voyager Therapeutics, Inc. - PEG multiplikatori|Neumora (NMRA) - Narx-foyda va o‘sish multiplikatori|SCLX: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tevogen Bio Inc. (TVGN)|Narx-foyda va o‘sish multiplikatori ACOG|PEG multiplikatori cogrx.com|Narx-foyda va o‘sish multiplikatori IKT (Inhibikase Therapeutics, Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAVA|PEG multiplikatori ASRT (Assertio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Coya Therapeutics Inc (COYA)|VistaGen Therapeutics Inc - PEG multiplikatori|Ovid Therapeutics Inc. (OVID) - Narx-foyda va o‘sish multiplikatori|ABOS: PEG multiplikatori|CervoMed, Inc. (CRVO) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Alterity Therapeutics Ltd.|Narxning foydaga va o‘sish sur’atiga nisbati CLNN|Narxning foydaga va o‘sish sur’atiga nisbati PepGen Inc. (PEPG)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati jupiterneurosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ANVS|GRCE: Narx-foyda va o‘sish multiplikatori|AIFF: Narxning foydaga va o‘sish sur’atiga nisbati|anewmeds.com (KLTO) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati NRSN (NeuroSense Therapeutics Ltd.)|MTVA (MetaVia Inc.) - PEG multiplikatori|NRXS: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|passagebio.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori NEUP (Neuphoria Therapeutics)|minervaneurosciences.com (NERV) - O‘sish sur’atiga tuzatilgan narx-foyda|ATHA: Narx-foyda va o‘sish multiplikatori|ADXN - PEG multiplikatori|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion Therapeutics, Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|O‘sish sur’atiga tuzatilgan narx-foyda Pasithea KTTA|Narxning foydaga va o‘sish sur’atiga nisbati Cortigent, Inc. (CRGT)|ATXI (Avenue Therapeutics Inc.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BCLI (Brainstorm Cell Therapeutics, Inc.)|Cara Therapeutics Inc (CARA) - O‘sish sur’atiga tuzatilgan narx-foyda|CHRO: Narx-foyda va o‘sish multiplikatori|ELYM: Narxning foydaga va o‘sish sur’atiga nisbati|ITCI: PEG multiplikatori|LBPH - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori MRNS|Narxning foydaga va o‘sish sur’atiga nisbati NKGN|PEG multiplikatori NRBO|PEG multiplikatori sagerx.com (SAGE)|Synaptogenix - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TRVN|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati WENA|CERE: PEG multiplikatori
